A private biotechnology startup called Arsenal Biosciences will receive $70 million from Roche in exchange for access to technology that...
Read moreDaiichi Sankyo, a Japanese company, has been concentrating on a series of antibody-drug conjugates, but it has achieved a world...
Read moreDespite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden...
Read moreEveryone eligible for both shots will often receive them at the same time during the COVID and flu vaccination campaigns...
Read moreIn order to ultimately enhance the outcomes and care for children and people with chronic conditions, especially as novel variants...
Read moreThe Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for...
Read moreAccording to a study published on September 22nd by U.S. researchers, those who had COVID-19 were more likely to experience a...
Read moreA quarter of patients with a variety of advanced tumours have shown signals of benefit from RP2, a modified form...
Read moreThe fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance from the European Commission for...
Read moreWithin one firm, the title of most costly treatment in the world has changed hands within a month. Bluebird Bio...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.